Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 8 (2011), Issue 4 (April)

1. Effect of massage therapy on stress levels and quality of life in brain tumor patients--observations from a pilot study.
   Support Care Cancer, 19(5): 711-5. [Abstract] [Full-text]
2. Glioblastoma cell lines derived under serum-free conditions can be used as an in vitro model system to evaluate therapeutic response.
   Cancer Lett, 305(1): 50-7. [Abstract] [Full-text]
3. Prophylactic cranial irradiation in lung cancer.
   Cancer Treat Rev, 37(4): 261-5. [Abstract] [Full-text]
4. Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.
   Cancer, 117(8): 1721-30. [Abstract] [Full-text]
5. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
   Cancer, 117(8): 1711-20. [Abstract] [Full-text]
6. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
   Cancer, 117(8): 1697-703. [Abstract] [Full-text]
7. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
   Cancer, 117(8): 1602-11. [Abstract] [Full-text]
8. Identification of factors involved in the anti-tumor activity of carnosine on glioblastomas using a proteomics approach.
   Cancer Invest, 29(4): 272-81. [Abstract] [Full-text]
9. Cardiac valve disease and low-dose dopamine agonist therapy: an artefact of reporting bias?
   Clin Endocrinol (Oxf), 74(5): 608-10. [Abstract] [Full-text]
10. Prognostic factors for survival in melanoma patients with brain metastases.
    Cancer, 117(8): 1687-96. [Abstract] [Full-text]
11. High-resolution morphological identification and characterization of living neuroblastoma SK-N-SH cells by hopping probe ion conductance microscopy.
    Brain Res, 1386: 35-40. [Abstract] [Full-text]
12. Signal intensity in T2' magnetic resonance imaging is related to brain glioma grade.
    Eur Radiol, 21(5): 1068-76. [Abstract] [Full-text]
13. Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.
    J Neurol Neurosurg Psychiatry, 82(5): 512-20. [Abstract] [Full-text]
14. Microwave beamforming for non-invasive patient-specific hyperthermia treatment of pediatric brain cancer.
    Phys Med Biol, 56(9): 2743-54. [Abstract] [Full-text]
15. Biomaterial-based vaccine induces regression of established intracranial glioma in rats.
    Pharm Res, 28(5): 1074-80. [Abstract] [Full-text]
16. Giant cell glioblastoma in the cerebrum of a pembroke welsh corgi.
    J Comp Pathol, 144(4): 324-7. [Abstract] [Full-text]
17. Acidic stress promotes a glioma stem cell phenotype.
    Cell Death Differ, 18(5): 829-40. [Abstract] [Full-text]
18. TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma.
    Cell Death Differ, 18(5): 853-63. [Abstract] [Full-text]
19. Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology?
    Stem Cell Rev, 7(2): 227-37. [Abstract] [Full-text]
20. Inter- and intrafraction patient positioning uncertainties for intracranial radiotherapy: a study of four frameless, thermoplastic mask-based immobilization strategies using daily cone-beam CT.
    Int J Radiat Oncol Biol Phys, 80(1): 281-90. [Abstract] [Full-text]
21. Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 80(1): 176-84. [Abstract] [Full-text]
22. Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy.
    Int J Radiat Oncol Biol Phys, 80(1): 169-75. [Abstract] [Full-text]
23. Long-term clinical outcomes following treatment of childhood craniopharyngioma.
    Pediatr Blood Cancer, 56(7): 1120-6. [Abstract] [Full-text]
24. Genomic profiles of glioma.
    Curr Neurol Neurosci Rep, 11(3): 291-7. [Abstract] [Full-text]
25. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Pediatr Blood Cancer, 56(7): 1032-40. [Abstract] [Full-text]
26. Current state of our knowledge on brain tumor epidemiology.
    Curr Neurol Neurosci Rep, 11(3): 329-35. [Abstract] [Full-text]
27. Role of cerebellum in fine speech control in childhood: persistent dysarthria after surgical treatment for posterior fossa tumour.
    Brain Lang, 117(2): 69-76. [Abstract] [Full-text]
28. Neurosurgery for brain tumors: update on recent technical advances.
    Curr Neurol Neurosci Rep, 11(3): 313-9. [Abstract] [Full-text]
29. Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial.
    Pediatr Blood Cancer, 56(7): 1046-54. [Abstract] [Full-text]
30. ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy.
    Pediatr Blood Cancer, 56(7): 1055-61. [Abstract] [Full-text]
31. Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence.
    Curr Neurol Neurosci Rep, 11(3): 305-12. [Abstract] [Full-text]
32. Validation of pediatric Functional Assessment of Cancer Therapy: patient version 2 of "brain tumor survivor" for grade school patients aged 7-12 years.
    Qual Life Res, 20(4): 529-35. [Abstract] [Full-text]
33. Are stereotactic sample biopsies still of value in the modern management of pineal region tumours? Lessons from a single-department, retrospective series.
    Acta Neurochir (Wien), 153(5): 1111-21; discussion 1121-2. [Abstract] [Full-text]
34. A 57-year-old female with a cerebellar mass.
    Brain Pathol, 21(3): 351-4. [Abstract] [Full-text]
35. 16 month-old female with intraventricular mass.
    Brain Pathol, 21(3): 349-50. [Abstract] [Full-text]
36. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
    Cancer Res, 71(8): 3066-75. [Abstract] [Full-text]
37. Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis.
    Cancer Sci, 102(5): 959-66. [Abstract] [Full-text]
38. Central nervous system marginal zone B-cell lymphoma associated with Chlamydophila psittaci infection.
    Hum Pathol, 42(5): 738-42. [Abstract] [Full-text]
39. The nature and timing of specific copy number changes in the course of molecular progression in diffuse gliomas: further elucidation of their genetic "life story".
    Brain Pathol, 21(3): 308-20. [Abstract] [Full-text]
40. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
    Neuroradiology, 53(5): 319-30. [Abstract] [Full-text]
41. Morbidity and tumor-related mortality among adult survivors of pediatric brain tumors: a review.
    Childs Nerv Syst, 27(5): 697-704. [Abstract] [Full-text]
42. Quantitative combination of volumetric MR imaging and MR spectroscopy data for the discrimination of meningiomas from metastatic brain tumors by means of pattern recognition.
    Magn Reson Imaging, 29(4): 525-35. [Abstract] [Full-text]
43. Harvey Cushing's early experience with pediatric gliomas.
    Childs Nerv Syst, 27(5): 819-24. [Abstract] [Full-text]
44. Ectopic recurrence of a craniopharyngioma in a 15-year-old girl 9 years after surgery and conventional radiotherapy: case report.
    Childs Nerv Syst, 27(5): 845-51. [Abstract] [Full-text]
45. Diffuse postoperative cerebellar swelling in medulloblastoma: report of two cases.
    Childs Nerv Syst, 27(5): 743-7. [Abstract] [Full-text]
46. Pathogenesis of pituitary tumors.
    Nat Rev Endocrinol, 7(5): 257-66. [Abstract] [Full-text]
47. Management of pituitary tumors in pregnancy.
    Nat Rev Endocrinol, 7(5): 301-10. [Abstract] [Full-text]
48. Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma.
    Radiology, 259(2): 540-9. [Abstract] [Full-text]
49. Serum-activated K and Cl currents underlay U87-MG glioblastoma cell migration.
    J Cell Physiol, 226(7): 1926-33. [Abstract] [Full-text]
50. Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas.
    J Cell Physiol, 226(7): 1879-88. [Abstract] [Full-text]
51. Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death.
    J Cell Physiol, 226(7): 1763-70. [Abstract] [Full-text]
52. Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells.
    J Agric Food Chem, 59(8): 4264-72. [Abstract] [Full-text]
53. TH1 predominance is associated with improved survival in pediatric medulloblastoma patients.
    Cancer Immunol Immunother, 60(5): 693-703. [Abstract] [Full-text]
54. Brain metastases as preventive and therapeutic targets.
    Nat Rev Cancer, 11(5): 352-63. [Abstract] [Full-text]
55. Pleural metastatic disease from glioblastoma multiforme.
    J Thorac Imaging, 26(2): W54-8. [Abstract] [Full-text]
56. Anterior temporal chordoid meningioma causing compressive optic neuropathy.
    Optom Vis Sci, 88(5): 645-51. [Abstract] [Full-text]
57. Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression.
    Brain Behav Immun, 25(4): 624-8. [Abstract] [Full-text]
58. Multicentric infantile hemangiopericytoma: case report and review of the literature.
    J Pediatr Hematol Oncol, 33(4): e166-70. [Abstract] [Full-text]
59. Outcome of central nervous system germinoma treatment by chemoradiation.
    J Pediatr Hematol Oncol, 33(4): e138-42. [Abstract] [Full-text]
60. Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas.
    Am J Pathol, 178(5): 1953-64. [Abstract] [Full-text]
61. The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma.
    Clin Imaging, 35(3): 165-73. [Abstract] [Full-text]
62. CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas.
    Biochem Biophys Res Commun, 407(4): 741-6. [Abstract] [Full-text]
63. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Biomaterials, 32(18): 4293-305. [Abstract] [Full-text]
64. Brain tumors and hormonal factors: review of the epidemiological literature.
    Cancer Causes Control, 22(5): 697-714. [Abstract] [Full-text]
65. Glycogen-rich pleomorphic xanthoastrocytoma with clear-cell features: confirmatory report of a rare variant with implications for differential diagnosis.
    Pathol Res Pract, 207(4): 256-61. [Abstract] [Full-text]
66. Neurosurgical robotic system for brain tumor removal.
    Int J Comput Assist Radiol Surg, 6(3): 375-85. [Abstract] [Full-text]
67. Nasoseptal "rescue" flap: a novel modification of the nasoseptal flap technique for pituitary surgery.
    Laryngoscope, 121(5): 990-3. [Abstract] [Full-text]
68. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
    Cancer Chemother Pharmacol, 67(5): 971-83. [Abstract] [Full-text]
69. Adenosine 5'-triphosphate-sensitive potassium channel activator induces the up-regulation of caveolin-1 expression in a rat brain tumor model.
    Cell Mol Neurobiol, 31(4): 629-34. [Abstract] [Full-text]
70. Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells.
    Int J Cancer, 129(1): 45-60. [Abstract] [Full-text]
71. Early toxicity predicts long-term survival in high-grade glioma.
    Br J Cancer, 104(9): 1365-71. [Abstract] [Full-text]
72. Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil.
    Cancer, 117(10): 2228-35. [Abstract] [Full-text]
73. MR spectroscopy differentiation between high and low grade astrocytomas: a comparison between paediatric and adult tumours.
    Eur J Paediatr Neurol, 15(3): 214-21. [Abstract] [Full-text]
74. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
    Ann Oncol, 22(5): 1154-63. [Abstract] [Full-text]
75. Nasal craniopharyngioma: case report and literature review.
    J Laryngol Otol, 125(5): 517-9. [Abstract] [Full-text]
76. Pharmacokinetics of 5-aminofluorescein-albumin, a novel fluorescence marker of brain tumors during surgery.
    J Clin Pharmacol, 51(5): 672-8. [Abstract] [Full-text]
77. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
    J Drug Target, 19(5): 382-90. [Abstract] [Full-text]
78. Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma.
    J Histochem Cytochem, 59(5): 489-503. [Abstract] [Full-text]
79. Protocol for the examination of specimens from patients with primary pituitary tumors.
    Arch Pathol Lab Med, 135(5): 640-6. [Abstract] [Full-text]
80. Molecular diagnostics of gliomas.
    Arch Pathol Lab Med, 135(5): 558-68. [Abstract] [Full-text]
81. Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer.
    Nat Rev Clin Oncol, 8(5): 302-6. [Abstract] [Full-text]
82. The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma.
    Eur J Cancer, 47(8): 1193-202. [Abstract] [Full-text]
83. Microvascular biodistribution of L19-SIP in angiogenesis targeting strategies.
    Eur J Cancer, 47(8): 1276-84. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.